Bibliography
Export 16 results:
Filters: Author is Gross,T. G. and Keyword is Humans [Clear All Filters]
Liver transplantation for primary or metastatic sarcoma to the liver. Am J Transplant. 2006;6(2):392-7.
Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956-7.
Malignancy after transplantation. Transplantation. 2005;80(2 Suppl):S254-64.
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc. 2005;37(2):954-5.
Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):958-9.
Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum. 2004;47(11):1898-903.
Donor transmitted malignancies. Ann Transplant. 2004;9(1):53-6.
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation. 2004;78(11):1676-82.
Posttransplant malignancy. Prog Transplant. 2004;14(3):193-200.
Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972-7.
Donors with central nervous system malignancies: are they truly safe? Transplantation. 2003;76(2):340-3.
The Israel Penn International Transplant Tumor Registry. AMIA Annu Symp Proc. 2003:1053.
De novo breast cancer in renal transplant recipients. Transplant Proc. 2002;34(5):1778-9.
Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780-1.
Incidental diagnosis of gastric cancer in transplant recipients improves patient survival. Surgery. 2002;132(4):754-8; - discussion - 758-60.